Rudolf Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
- Revenue Growth -3.93%
- Profit Growth 0.43%
- Ebitda -222.46%
- Net Worth 5.27%
- Total Assets 7.92%
About Rudolf Life Sciences
Rudolf Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2014 and has a history of Ten years and nine months. Its registered office is in Panipat, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 M.
Manoj Khurana and Om Khurana serve as directors at the Company.
Company Details
-
Location
Panipat, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909HR2014PTC052399
-
Company No.
052399
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 May 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Rudolf Life Sciences Private Limited offer?
Rudolf Life Sciences Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Liquid Orals.
Who are the key members and board of directors at Rudolf Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Khurana
|
Director | 16-May-2014 | Current |
|
Om Khurana
|
Director | 16-May-2014 | Current |
Financial Performance of Rudolf Life Sciences.
Rudolf Life Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.93% decrease. The company also saw a slight improvement in profitability, with a 0.43% increase in profit. The company's net worth moved up by a moderate rise of 5.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rudolf Life Sciences?
In 2018, Rudolf Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- The Panipat Urban Co-Operative Bank Ltd : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2014 | The Panipat Urban Co-Operative Bank Ltd | ₹1.50 M | Open |
How Many Employees Work at Rudolf Life Sciences?
Unlock and access historical data on people associated with Rudolf Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rudolf Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rudolf Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.